Seller record · Telehealth service

Refills

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published. The product page describes potency, sterility, pH and endotoxin testing and says a patient can request a certificate of analysis, with no document posted.

At a glance

RefillsTelehealth service

7/8criteria passed

Price: GLP-1 injections from $5 a day
Sells: personalized GLP-1 injection (compounded semaglutide), and 8 more
FDA letters: 1 on file

Visit Refills See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth store selling compounded GLP-1 and GIP plus GLP-1 injections, NAD+ and sermorelin injections, and hair loss and sexual health prescriptions through outside clinician groups. Care starts with an online health survey reviewed by a licensed provider, and it names two filling pharmacies with street addresses.

Operating entity Refills Health, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Refills' how it works page; Refills' personalized GLP-1 injection page
S2	Prescription gating	PASS	Refills' how it works page; Refills' personalized GLP-1 injection page
S3	Pharmacy identification	PASS	Refills' our pharmacy partner page
S4	Compounding disclosure	PASS	Refills' personalized GLP-1 injection page; Refills' our pharmacy partner page
S5	Analytical documentation	FAIL	Refills' personalized GLP-1 injection page
S6	Business address	PASS	Refills' contact page; Refills' privacy policy; Refills' terms and conditions
S7	Price disclosure	PASS	Refills' personalized GLP-1 injection page; Refills' weight loss page
S8	Enforcement status	PASS	FDA's website; FDA warning letter 721475

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider in the patient's state reviews each online intake and prescribes only if the patient is eligible, and the disclaimer says independent clinicians from partner medical groups make every prescribing decision.Source: Refills' how it works page; Refills' personalized GLP-1 injection page.

S2PASSThe product and how-it-works pages list an online health survey as the first step, reviewed by a licensed provider before any prescription, with the medication processed and shipped only once approved.Source: Refills' how it works page; Refills' personalized GLP-1 injection page.

S3PASSThe pharmacy partner page names two dispensing pharmacies with street addresses: Perfect Rx Pharmacy, operated by PERFECTRX LLC, at 1911 Jeter Road, Bartonville, TX 76226, and Hallandale Pharmacy LLC at 2666 SW 36th St, Fort Lauderdale, FL 33312.Source: Refills' our pharmacy partner page.

S4PASSThe product pages and the disclaimer on every page say compounded drug products are not approved or evaluated for safety, effectiveness or quality by the FDA.Source: Refills' personalized GLP-1 injection page; Refills' our pharmacy partner page.

S5FAILNo certificate of analysis or lot document is published. The product page describes potency, sterility, pH and endotoxin testing and says a patient can request a certificate of analysis, with no document posted.Source: Refills' personalized GLP-1 injection page.

S6PASSRefills Health, LLC at 1401 Pennsylvania Ave, Suite 105, Wilmington, DE 19806, printed on the contact page, in the privacy policy and in the terms, which name Delaware law.Source: Refills' contact page; Refills' privacy policy; Refills' terms and conditions.

S7PASSThe product pages give the personalized GLP-1 and GIP plus GLP-1 injections from as low as $5 a day, and the weight loss page labels both 40% off without printing a dollar price. No monthly price by medication or dose is printed, and shipping is free.Source: Refills' personalized GLP-1 injection page; Refills' weight loss page.

S8PASSFDA warning letter 721475, February 2026, names Refills Health, LLC dba Refills Health at the Wilmington, Delaware address the site prints, alleging that pictured labels presented Refills Health as the compounder of its semaglutide and that claims such as clinically proven and the same active ingredient found in certain FDA approved treatments implied FDA approval. No close-out letter appears in the index. No FDA action has halted the business, and the seller still trades.Source: FDA's website; FDA warning letter 721475.

Products shown on the seller's own pages at the recorded date: personalized GLP-1 injection (compounded semaglutide), personalized GIP + GLP-1 injection, NAD+ injections, sermorelin injections, tadalafil, sildenafil, finasteride, oral minoxidil, finasteride and minoxidil spray.

Other sellers of the same products

Who sells semaglutide Who sells sermorelin Who sells NAD+

Enforcement documents on file: 1 warning letter

FDA warning letter 721475, issued February 2026, to Refills Health, LLC dba Refills HealthPictured labels identify Refills Health as the compounder of semaglutide products when it is not, and claims such as clinically proven and the same active ingredient found in certain FDA approved treatments imply the compounded products have been FDA-approved when they have not.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Refills

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.